These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 30151922)
1. Piperazine derivatives with central pharmacological activity used as therapeutic tools. Brito AF; Moreira LKS; Menegatti R; Costa EA Fundam Clin Pharmacol; 2019 Feb; 33(1):13-24. PubMed ID: 30151922 [TBL] [Abstract][Full Text] [Related]
2. Tert-butyl 4-((1-phenyl-1H-pyrazol-4-yl) methyl) piperazine-1-carboxylate (LQFM104)- New piperazine derivative with antianxiety and antidepressant-like effects: Putative role of serotonergic system. da Silva DM; Sanz G; Vaz BG; de Carvalho FS; Lião LM; de Oliveira DR; Moreira LKDS; Cardoso CS; de Brito AF; da Silva DPB; da Rocha FF; Santana IGC; Galdino PM; Costa EA; Menegatti R Biomed Pharmacother; 2018 Jul; 103():546-552. PubMed ID: 29677541 [TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice. Donahue TJ; Hillhouse TM; Webster KA; Young R; De Oliveira EO; Porter JH Psychopharmacology (Berl); 2017 Dec; 234(23-24):3507-3520. PubMed ID: 28921163 [TBL] [Abstract][Full Text] [Related]
5. A new piperazine derivative: 1-(4-(3,5-di-tert-butyl-4-hydroxybenzyl) piperazin-1-yl)-2-methoxyethan-1-one with antioxidant and central activity. Brito AF; Braga PCCS; Moreira LKS; Silva DM; Silva DPB; Sanz G; Vaz BG; de Carvalho FS; Lião LM; Silva RR; Noël F; Neri HFS; Ghedini PC; de Carvalho MF; de S Gil E; Costa EA; Menegatti R Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):255-269. PubMed ID: 29260264 [TBL] [Abstract][Full Text] [Related]
6. The antidepressant- and anxiolytic-like activities of new xanthone derivative with piperazine moiety in behavioral tests in mice. Pytka K; Żmudzka E; Lustyk K; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Barbara F Indian J Pharmacol; 2016; 48(3):286-91. PubMed ID: 27298499 [TBL] [Abstract][Full Text] [Related]
7. SYNTHESIS, STRUCTURE AND PHARMACOLOGICAL EVALUATION OF 1-(1H-PYRROL-1-YLMETHYL)-4-AZATRICYCLO[5.2.1.0(2,6)] DEC-8-ENE-3,5-DIONE. Pakosińska-Parys M; Zimniak A; Chodkowska A; Jagiełło-Wójtowicz E; Głowala M; Struga M Acta Pol Pharm; 2016 Jul; 73(4):931-936. PubMed ID: 29648718 [TBL] [Abstract][Full Text] [Related]
8. The anxiolytic-like activity of a novel N-cycloalkyl-N-benzoylpiperazine derivative. Strub DJ; Sałat K; Librowski T; Lochyński S; Gaweł M; Podkowa A Pharmacol Rep; 2016 Feb; 68(1):62-5. PubMed ID: 26721353 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review. Karrouchi K; Radi S; Ramli Y; Taoufik J; Mabkhot YN; Al-Aizari FA; Ansar M Molecules; 2018 Jan; 23(1):. PubMed ID: 29329257 [TBL] [Abstract][Full Text] [Related]
10. Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents. Fernández J; Alonso JM; Andrés JI; Cid JM; Díaz A; Iturrino L; Gil P; Megens A; Sipido VK; Trabanco AA J Med Chem; 2005 Mar; 48(6):1709-12. PubMed ID: 15771415 [TBL] [Abstract][Full Text] [Related]
11. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838 [TBL] [Abstract][Full Text] [Related]
12. [The GABA-ergic component of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives]. Abramets II; Talalaenko AN; Stakhovskiĭ IuV Eksp Klin Farmakol; 1992; 55(6):5-7. PubMed ID: 1363956 [TBL] [Abstract][Full Text] [Related]
13. The future of 5-HT1A receptor agonists. (Aryl-piperazine derivatives). Murasaki M; Miura S Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):833-45. PubMed ID: 1355301 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Guilloux JP; Mendez-David I; Pehrson A; Guiard BP; Repérant C; Orvoën S; Gardier AM; Hen R; Ebert B; Miller S; Sanchez C; David DJ Neuropharmacology; 2013 Oct; 73():147-59. PubMed ID: 23721744 [TBL] [Abstract][Full Text] [Related]
15. The medicinal chemistry of piperazines: A review. Faizan M; Kumar R; Mazumder A; Salahuddin ; Kukreti N; Kumar A; Chaitanya MVNL Chem Biol Drug Des; 2024 Jun; 103(6):e14537. PubMed ID: 38888058 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 2-amino-5-sulfanyl-1,3,4-thiadiazole derivatives and evaluation of their antidepressant and anxiolytic activity. Clerici F; Pocar D; Guido M; Loche A; Perlini V; Brufani M J Med Chem; 2001 Mar; 44(6):931-6. PubMed ID: 11300875 [TBL] [Abstract][Full Text] [Related]
17. Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent. Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Kazek G; Bojarski AJ; Piaskowska A; Kalinowska-Tłuścik J; Partyka A; Wesołowska A Bioorg Med Chem; 2015 Jul; 23(13):3436-47. PubMed ID: 25936259 [TBL] [Abstract][Full Text] [Related]
18. Piperazine skeleton in the structural modification of natural products: a review. Zhang RH; Guo HY; Deng H; Li J; Quan ZS J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1165-1197. PubMed ID: 34080510 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity. Zagórska A; Kołaczkowski M; Bucki A; Siwek A; Kazek G; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pawłowski M Eur J Med Chem; 2015 Jun; 97():142-54. PubMed ID: 25965777 [TBL] [Abstract][Full Text] [Related]
20. Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity. Bucki A; Marcinkowska M; Śniecikowska J; Więckowski K; Pawłowski M; Głuch-Lutwin M; Gryboś A; Siwek A; Pytka K; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Mierzejewski P; Kołaczkowski M J Med Chem; 2017 Sep; 60(17):7483-7501. PubMed ID: 28763213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]